Voyageur Pharmaceuticals Ltd. (CVE:VM – Get Free Report) shares traded up 47.4% during trading on Friday . The company traded as high as C$0.14 and last traded at C$0.14. 1,229,210 shares traded hands during trading, an increase of 502% from the average session volume of 204,168 shares. The stock had previously closed at C$0.10.
Voyageur Pharmaceuticals Price Performance
The firm’s 50-day moving average is C$0.07 and its 200-day moving average is C$0.06. The company has a market capitalization of C$19.53 million, a PE ratio of -14.00 and a beta of 0.32. The company has a quick ratio of 0.84, a current ratio of 0.17 and a debt-to-equity ratio of 3.21.
Voyageur Pharmaceuticals Company Profile
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.
Read More
- Five stocks we like better than Voyageur Pharmaceuticals
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Driving Forward: Lucid’s Growing Sales and Gravity SUV’s Impact
- Business Services Stocks Investing
- Why Amazon’s Next Earnings Could Trigger a Stock Breakout
- What Are Trending Stocks? Trending Stocks Explained
- With This Kind of Data, The Fed Isn’t Cutting Rates This Year
Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
